Heart Failure Fundamentals (Pre-Recorded)Heart Failure Epidemiology and Risk FactorsSadiya KhanPathophysiology I: Cellular and Energetic Considerations

Daniel Burkhoff

• Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations

Daniel Burkhoff

• Diagnosis and Clinical Assessment

Mark Drazner

• Cardio-Oncology for the HF boards

Bonnie Ky

• Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards

Jon Lomasney

• Statistics for the HF Board

Brian Claggett
Cardiac Transplantation

• Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies

Nancy Sweitzer

• lmmunology: The Basics, PRA, Sensitization, Crossmatch

Sean Pinney

• Rejection: Cellular and Antibody Mediated

Sean Pinney

• Managing Immunosuppression and Drugs

Michelle Kittleson

• Heart Transplant, Clinical Outcomes and Complications

Michelle Kittleson

• Q&A Panel I

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
Key Issues in HF Management

• Hemodynamics in HF I

James Fang

• Hemodynamics in HF II

James Fang

• Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)

Clyde Yancy

• Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)

Mark Drazner

• HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)

Sanjiv Shah

• Pulmonary Hypertension

Jonathan Rich

• Management of Common Arrhythmias I – Atrial Fib and Flutter

Roderick Tung

• Management of Common Arrhythmias in HF II

Roderick Tung

• Device Therapy in Heart Failure I – Sudden Death Prevention

Wendy Tzou

• Device Therapy in Heart Failure II – CRT

Wendy Tzou

• Management of the Hospitalized HF Patient

Maria Rosa Costanzo

• Cardio Renal Failure Interactions in Heart Failure

Jeff Testani
Specific Heart Failure Syndromes

• Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)

Akshay Desai

• Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)

Jane Wilcox

• Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)

Sanjiv Shah

• Q&A Panel II

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
Guest: James Fang
Shock/MCS

• Cardiogenic Shock Management

Nancy Sweitzer

• MCS I: Durable MCS Devices and Outcomes

Joseph Rogers

• MCS II: Temporary Support Devices and ECMO for the Boards

Jennifer Cowger

• MCS III: MCS Complications and Patient Management

Jennifer Cowger

• MCS IV: Interactive Shock and Device Management

Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer
Special Topics in HF

• Assessment of Functional Capacity including cardiopulmonary exercise testing

Gregory Lewis

• Adult Congenital Heart Disease for the HF Specialist

Eric Krieger

• Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)

Akshay Desai

• Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)

Jane Wilcox

• Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD

Maria Rosa Costanzo

• Q&A Panel III

Akshay Desai, Nancy Sweitzer, Jonathan Rich